Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Propylhexedrine
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Short description|Topical nasal decongestant}}{{good article}} {{Use dmy dates|date=September 2021}} {{cs1 config|name-list-style=vanc|display-authors=6}} {{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 464217507 | drug_name = Propylhexedrine | IUPAC_name = (Β±)-1-cyclohexyl-''N''-methylpropan-2-amine | image = Propylhexedrine.svg | image_class = skin-invert-image | imageL = Propylhex_3d.png | image_classL = bg-transparent | widthL = | altL = | imageR = Propylhex_3d (R).png | image_classR = bg-transparent | widthR = | altR = | captionLR = Left: (''S'')-Propylhexedrine<br/>Right: (''R'')-Propylhexedrine <!--Clinical data-->| tradename = Benzedrex, Obesin, Dristan Inhaler, and others | Drugs.com = {{drugs.com|monograph|propylhexedrine}} | pregnancy_category = C | legal_AU = S4 | legal_BR = B1 | legal_BR_comment = | legal_CA = Unscheduled | legal_DE = [[Prescription drug|Prescription Only]] | legal_US = OTC | legal_UN = Unscheduled | legal_UK = P | routes_of_administration = Medical: [[Intranasal]] (inhaler)<br />Recreational: [[By mouth|Oral]], [[parenteral]] <!--Pharmacokinetic data-->| bioavailability = | protein_bound = | metabolism = | elimination_half-life = 4 Β± 1.5 hours | excretion = <!--Identifiers--> | index2_label = hydrochloride | CAS_number_Ref = {{cascite|correct|CAS}} | CAS_number = 101-40-6 | CAS_number2_Ref = {{cascite|correct|CAS}} | CAS_number2 = 1007-33-6 | ATC_prefix = N06BA | ATC_suffix = | ATC_supplemental = | PubChem = 7558 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB06714 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 7277 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = LQU92IU8LL | UNII2_Ref = {{fdacite|correct|FDA}} | UNII2 = 064LUN7NZ5 | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D05637 | synonyms = 1-cyclohexyl-2-methylaminopropane | C = 10 | H = 21 | N = 1 | SMILES = N(C(CC1CCCCC1)C)C | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C10H21N/c1-9(11-2)8-10-6-4-3-5-7-10/h9-11H,3-8H2,1-2H3 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = JCRIVQIOJSSCQD-UHFFFAOYSA-N | chirality = [[Racemic mixture]] }} '''Propylhexedrine''', sold under the brand name '''Benzedrex''' among others, is an [[Psychotropic alkylamines|alkylamine]] primarily utilized as a [[Topical decongestant|topical nasal decongestant]].<ref>{{Cite web |date=June 7, 2023 |title=Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use |url=https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=341.20 |archive-url=https://web.archive.org/web/20230706041627/https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=341.20 |archive-date=6 July 2023 |access-date=July 5, 2023 |website=[[FDA]] }}</ref> Its main indications are relief of congestion due to [[Common cold|colds]], [[Allergy|allergies]], and [[allergic rhinitis]].<ref name="Daily Med">{{Cite web |title=BENZEDREX 09-19-2014- propylhexedrine inhalant |url=https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=03a8ef3c-a808-6208-e054-00144ff8d46c |archive-url=https://archive.today/20230716000914/https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=03a8ef3c-a808-6208-e054-00144ff8d46c |archive-date=July 16, 2023 |access-date=July 15, 2023 |work=Daily Med |publisher=U.S. National Library of Medicine}}</ref> Propylhexedrine was first used medically in 1949, with the release of Benzedrex by [[Smith, Kline & French]], and it has been used, mainly within the United States, since then.<ref name="Schwarez" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)